SMN2 and proximal spinal muscular atrophy: To evaluate this compound in patients’ samples, we examined the effect of Z-FA-FMK on the mRNA and protein expression of SMN in fibroblast cells of SMA patients (GM03813 and GM22592, which were initially diagnosed as type I and type II SMA, respectively).